Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'tissue factor pathway inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 195 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kaiser, B; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Chan, JCY
      Gene targeting in hemostasis. Tissue factor pathway inhibitor

      FRONTIERS IN BIOSCIENCE
    3. Grabowski, EF; Reininger, AJ; Petteruti, PG; Tsukurov, O; Orkin, RW
      Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Chen, AH; Frangos, SG; Kilaru, S; Sumpio, BE
      Intermittent pneumatic compression devices - Physiological mechanisms of action

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    5. Cella, G; Sbarai, A; Mazzaro, G; Vanzo, B; Romano, S; Hoppensteadt, D; Fareed, J
      Plasma markers of endothelial dysfunction in chronic obstructive pulmonarydisease

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    6. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    7. Kojima, T; Gando, S; Kemmotsu, O; Mashio, H; Goda, Y; Kawahigashi, H; Watanabe, N
      Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: Role of tissue factor pathway inhibitor

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    8. Ohan, J; Leseche, G; Gilbert, MA; Trugnan, G; Drouet, L
      Human mesothelial cells express tissue factor when switched to proliferating state. Pharmacological modulation in vitro

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Bendz, B; Sevre, K; Andersen, TO; Sandset, PM
      Low molecular weight heparin prevents activation of coagulation in a hypobaric environment

      BLOOD COAGULATION & FIBRINOLYSIS
    10. Moatti, D; Meirhaeghe, A; Ollivier, V; Bauters, C; Amouyel, P; de Prost, D
      Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty

      BLOOD COAGULATION & FIBRINOLYSIS
    11. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Saito, M; Morishita, E; Yamazaki, M; Suga, Y; Takami, A; Miyamoto, K; Nakao, S
      Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases

      BLOOD COAGULATION & FIBRINOLYSIS
    12. Matyal, R; Vin, Y; Delude, RL; Lee, C; Creasey, AA; Fink, MP
      Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock

      INTENSIVE CARE MEDICINE
    13. Kereveur, A; Enjyoji, K; Masuda, K; Yutani, C; Kato, H
      Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1

      THROMBOSIS AND HAEMOSTASIS
    14. Brown, JR; Kuter, DJ
      The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients

      THROMBOSIS AND HAEMOSTASIS
    15. Iakhiaev, A; Ruf, W; Rao, LVM
      The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    16. Eling, M; Stephens, AC; Oragui, EE; Rivers, RPA; Levin, M
      Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease

      THROMBOSIS AND HAEMOSTASIS
    17. Uszynski, M; Zekanowska, E; Uszynski, W; Kuczynski, J
      Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    18. Roldan, V; Marin, F; Fernandez, P; Lujan, J; Martinez, JG; Pineda, J; Marco, P; Sogorb, F
      Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    19. Levi, M; de Jonge, E; van der Poll, T
      Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation

      CRITICAL CARE MEDICINE
    20. Creasey, AA; Reinhart, K
      Tissue factor pathway inhibitor activity in severe sepsis

      CRITICAL CARE MEDICINE
    21. Gando, S; Nanzaki, S; Morimoto, Y; Ishitani, T; Kemmotsu, O
      Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients

      CRITICAL CARE MEDICINE
    22. Abraham, E; Reinhart, K; Svoboda, P; Seibert, A; Olthoff, D; Dal Nogare, A; Postier, R; Hempelmann, G; Butler, T; Martin, E; Zwingelstein, C; Percell, S; Shu, V; Leighton, A; Creasey, AA
      Assessment of the safety of recombinant tissue factor pathway inhibitor inpatients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

      CRITICAL CARE MEDICINE
    23. Opal, SM; Palardy, JE; Parejo, NA; Creasey, AA
      The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis

      CRITICAL CARE MEDICINE
    24. Dhainaut, JF; Vallet, B
      Combined procoagulant and innate immune responses to infection: Toward more potent drugs in septic patients

      CRITICAL CARE MEDICINE
    25. Hoppensteadt, DA; Fareed, J; Raake, P; Raake, W
      Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates

      THROMBOSIS RESEARCH
    26. Hansen, JB; Grimsgaard, S; Huseby, NE; Sandset, PM; Bonaa, KH
      Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men

      THROMBOSIS RESEARCH
    27. Vambergue, A; Rugeri, L; Gaveriaux, V; Devos, P; Martin, A; Fermon, C; Fontaine, P; Jude, B
      Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor indiabetes mellitus: Influence of type of diabetes, obesity index, and age

      THROMBOSIS RESEARCH
    28. Tsuji, R; Tatsumi, N; Hino, M; Nishioka, T; Takubo, T
      Tissue factor pathway inhibitor as a universal anticoagulant for use in clinical laboratory tests

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    29. Morishita, E; Asakura, H; Saito, M; Yamazaki, M; Ontachi, Y; Mizutani, T; Kato, M; Matsuda, T; Nakao, S
      Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients

      ATHEROSCLEROSIS
    30. Cella, G; Bellotto, F; Tona, F; Sbarai, A; Mazzaro, G; Motta, G; Fareed, J
      Plasma markers of endothelial dysfunction in pulmonary hypertension

      CHEST
    31. Rigla, M; Fontcuberta, J; Mateo, J; Caixas, A; Pou, JM; de Leiva, A; Perez, A
      Physical training decreases plasma thrombomodulin in Type I and Type II diabetic patients

      DIABETOLOGIA
    32. Zillmann, A; Luther, T; Muller, I; Kotzsch, M; Spannagl, M; Kauke, T; Oelschlagel, U; Zahler, S; Engelmann, B
      Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    33. Faust, SN; Heyderman, RS; Levin, M
      Disseminated intravascular coagulation and purpura fulminans secondary to infection

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    34. Takeshima, H; Nishi, T; Kuratsu, J; Kamikubo, Y; Kochi, M; Ushio, Y
      Suppression of the tissue factor-dependent coagulation cascade: A contributing factor for the development of intratumoral hemorrhage ire glioblastoma

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    35. Crawley, J; Lupu, F; Westmuckett, AD; Severs, NJ; Kakkar, VV; Lupu, C
      Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    36. Westmuckett, AD; Lupu, C; Roquefeuil, S; Krausz, T; Kakkar, VV; Lupu, F
      Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    37. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    38. Bladbjerg, EM; Larsen, LF; Ostergaard, P; Jespersen, J
      In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy

      BLOOD COAGULATION & FIBRINOLYSIS
    39. Iversen, N; Strekerud, FG; Abildgaard, U
      Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex

      BLOOD COAGULATION & FIBRINOLYSIS
    40. Adams, MJ; Oostryck, R
      A comparative study of functional assays for tissue factor pathway inhibitor using normal plasma and clinical samples

      BLOOD COAGULATION & FIBRINOLYSIS
    41. Bendz, B; Andersen, TO; Sandset, PM
      Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

      BLOOD COAGULATION & FIBRINOLYSIS
    42. Mukherjee, M; Ranlall, N; Patel, G; Rutlin, A; Jehanli, A; Kakkar, VV
      Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease

      BLOOD COAGULATION & FIBRINOLYSIS
    43. van Leeuwen, EBM; Veenstra, R; van Wijk, R; Molema, G; Hoekstra, A; Ruiters, MHJ; van der Meer, J
      Characterization of immortalized human umbilical and iliac vein endothelial cell lines after transfection with SV40 large T-antigen

      BLOOD COAGULATION & FIBRINOLYSIS
    44. Armaganian, L; Kam, G; Eisenberg, PR; Schechtman, KB; Abendschein, DR
      Role of tissue factor-mediated coagulation in ischemia/reperfusion-inducedinjury of Langendorf-perfused rabbit hearts

      CORONARY ARTERY DISEASE
    45. Sun, LB; Utoh, J; Kunitomo, R; Tsurusaki, S; Tagami, H; Hirata, T; Moriyama, S; Okamoto, K; Kitamura, N
      Altered plasma antigen levels of tissue factor pathway inhibitor during open-heart surgery

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    46. Bajaj, MS; Pendurthi, U; Koenig, K; Pueblitz, S; Idell, S
      Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells

      EUROPEAN RESPIRATORY JOURNAL
    47. Roubey, RAS
      Tissue factor pathway and the antiphospholipid syndrome

      JOURNAL OF AUTOIMMUNITY
    48. Hedner, U; Erhardtsen, E
      Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI

      ANNALS OF MEDICINE
    49. Edstrom, CS; Calhoun, DA; Christensen, RD
      Expression of tissue factor pathway inhibitor in human fetal and placentaltissues

      EARLY HUMAN DEVELOPMENT
    50. Wang, GP; Deng, ZD; Ni, J
      Oxidized low density lipoprotein inhibited tissue factor pathway inhibitormRNA expression in human endothelial cells

      CHINESE MEDICAL JOURNAL
    51. Moatti, D; Haidar, B; Fumeron, F; Gauci, L; Boudvillain, O; Seknadji, P; Ollivier, V; Aumont, MC; de Prost, D
      A new T-287C polymorphism in the 5 ' regulatory region of the tissue factor pathway inhibitor gene - Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels

      THROMBOSIS AND HAEMOSTASIS
    52. Philippou, H; Adami, A; Davidson, SJ; Pepper, JR; Burman, JF; Lane, DA
      Tissue factor is rapidly elevated in plasma collected from the pericardialcavity during cardiopulmonary bypass

      THROMBOSIS AND HAEMOSTASIS
    53. Kazama, Y; Kamei, S; Kuijper, JL; Foster, DC; Kisiel, W
      Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2

      THROMBOSIS AND HAEMOSTASIS
    54. Sandset, PR; Bendz, B; Hansen, JB
      Physiological function of tissue factor pathway inhibitor and interaction with heparins

      HAEMOSTASIS
    55. Yamamoto, N; Ogawa, H; Oshima, S; Soejima, H; Fujii, H; Misumi, K; Takazoe, K; Mizuno, Y; Noda, K; Saito, T; Tsuji, I; Kumeda, K; Nakamura, S; Yasue, H
      The effect of heparin on tissue factor and tissue factor pathway inhibitorin patients with acute myocardial infarction

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    56. Fareed, J; Hoppensteadt, DA; Bick, RL
      An update on heparins at the beginning of the new millennium

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    57. Levi, M; de Jonge, E; van der Poll, T; ten Cate, H
      Novel approaches to the management of disseminated intravascular coagulation

      CRITICAL CARE MEDICINE
    58. Abraham, E
      Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis

      CRITICAL CARE MEDICINE
    59. Thijs, LG
      Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach

      CRITICAL CARE MEDICINE
    60. Fujii, M; Hayakawa, H; Urano, T; Sato, A; Chida, K; Nakamura, H; Takada, A
      Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis

      THROMBOSIS RESEARCH
    61. Cella, G; Burlina, A; Sbarai, A; Motta, G; Girolami, A; Berrettini, M; Strauss, W
      Tissue factor pathway inhibitor levels in patients with homocystinuria

      THROMBOSIS RESEARCH
    62. Wiiger, MT; Pringle, S; Pettersen, KS; Narahara, N; Prydz, H
      Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells

      THROMBOSIS RESEARCH
    63. Bendz, B; Andersen, TO; Sandset, PM
      A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1

      THROMBOSIS RESEARCH
    64. Larsen, LF; Marckmann, P; Bladbjerg, EM; Ostergaard, PB; Sidelmann, J; Jespersen, J
      The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    65. Malyszko, JS; Malyszko, J; Pawlak, K; Pawlak, D; Buczko, W; Mysliwiec, M
      Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin

      NEPHRON
    66. Blann, AD; Amiral, J; McCollum, CN; Lip, GYH
      Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls

      ATHEROSCLEROSIS
    67. Izumi, H; Takahashi, C; Oh, J; Noda, M
      Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes

      FEBS LETTERS
    68. Kim, HK; Song, KS; Park, YS; Yun, YS; Shim, WH
      Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease

      CARDIOLOGY
    69. Mukherjee, M
      The effect of heparin removal in vitro on the activity of tissue factor pathway inhibitor

      BRITISH JOURNAL OF HAEMATOLOGY
    70. McVey, JH
      Tissue Factor pathway

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    71. Martin, JF; Smith, REA; Mathur, A
      Endogenous mediators and thrombophilia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    72. Yutani, C; Imakita, M; Ishibashi-Ueda, H; Tsukamoto, Y; Nishida, N; Ikeda, Y
      Coronary atherosclerosis and interventions: Pathological sequences and restenosis

      PATHOLOGY INTERNATIONAL
    73. Lupu, C; Poulsen, E; Roquefeuil, S; Westmuckett, AD; Kakkar, VV; Lupu, F
      Cellular effects of heparin on the production and release of tissue factorpathway inhibitor in human endothelial cells in culture

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    74. St Pierre, J; Yang, LY; Tamirisa, K; Scherrer, D; De Ciechi, P; Eisenberg, P; Tolunay, E; Abendschein, D
      Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    75. Ettelaie, C; Wilbourn, BR; Adam, JM; James, NJ; Bruckdorfer, KR
      Comparison of the inhibitory effects of ApoB100 and tissue factor pathway inhibitor on tissue factor and the influence of lipoprotein oxidation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    76. Moatti, D; Seknadji, P; Galand, C; Poirier, O; Fumeron, F; Desprez, S; Garbarz, M; Dhermy, D; Arveiler, D; Evans, A; Luc, G; Ruidavets, JB; Ollivier, V; Hakim, J; Aumont, MC; de Prost, D
      Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects - Impact of the V264M substitution on plasma levels of TFPI

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    77. Chouhan, VD; Comerota, AJ; Sun, L; Hada, R; Gaughan, JP; Rao, AK
      Inhibition of tissue factor pathway during intermittent pneumatic compression - A possible mechanism for antithrombotic effect

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    78. Han, X; Girard, TJ; Baum, P; Abendschein, DR; Broze, GJ
      Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    79. Wakita, Y; Wada, H; Nakase, T; Nakasaki, T; Shimura, M; Hiyoyama, K; Mori, S; Gabazza, EC; Nishikawa, M; Deguchi, K; Shiku, H
      Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    80. Harris, GM; Stendt, CL; Vollenhoven, BJ; Gan, TE; Tipping, PG
      Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives

      AMERICAN JOURNAL OF HEMATOLOGY
    81. Suzuki, M; Kudo, A; Otawara, Y; Hirashima, Y; Takaku, A; Ogawa, A
      Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage

      NEUROSURGERY
    82. Gando, S; Nanzaki, S; Morimoto, Y; Kobayashi, S; Kemmotsu, O
      Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation

      THROMBOSIS RESEARCH
    83. Petit, L; Lesnik, P; Dachet, C; Hugou, I; Moreau, M; Chapman, J; Rouis, M
      The promoter of human tissue factor pathway inhibitor gene: Identificationof potential regulatory elements

      THROMBOSIS RESEARCH
    84. Sato, Y; Kataoka, H; Asada, Y; Marutsuka, K; Kamikubo, Y; Koono, M; Sumiyoshi, A
      Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor factor VIIa complex

      THROMBOSIS RESEARCH
    85. Jacobsen, EM; Sandset, PM; Wisloff, F
      Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?

      THROMBOSIS RESEARCH
    86. Kamei, S; Petersen, LC; Sprecher, CA; Foster, DC; Kisiel, W
      Inhibitory properties of human recombinant Arg(24)-> Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2)

      THROMBOSIS RESEARCH
    87. Iochmann, S; Reverdiau-Moalic, P; Beaujean, S; Rideau, E; Lebranchu, Y; Bardos, P; Gruel, Y
      Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription polymerase chain reaction

      THROMBOSIS RESEARCH
    88. Soejima, H; Ogawa, H; Yasue, H; Nishiyama, K; Kaikita, K; Misumi, K; Takazoe, K; Kugiyama, K; Tsuji, I; Kumeda, K; Nakamura, S
      Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris

      THROMBOSIS RESEARCH
    89. Kaikita, K; Takeya, M; Ogawa, H; Suefuji, H; Yasue, H; Takahashi, K
      Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis

      JOURNAL OF PATHOLOGY
    90. Zhang, E; St Charles, R; Tulinsky, A
      Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant

      JOURNAL OF MOLECULAR BIOLOGY
    91. Ettelaie, C; Adam, JM; James, NJ; Oke, AO; Harrison, JA; Bunce, TD; Bruckdorfer, KR
      The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor

      FEBS LETTERS
    92. Nishi, T; Goto, T; Takeshima, H; Hamada, K; Tada, K; Saito, Y; Kochi, M; Kuratsu, J; Ushio, Y
      Tissue factor expressed in pituitary adenoma cells contributes to the development of vascular events in pituitary adenomas

      CANCER
    93. Bendz, B; Hansen, JB; Andersen, TO; Ostergaard, P; Sandset, PM
      Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

      BRITISH JOURNAL OF HAEMATOLOGY
    94. Liu, YY; Stack, SM; Lakka, SS; Khan, AJ; Woodley, DT; Rao, JS; Rao, CN
      Matrix localization of tissue factor pathway inhibitor-2/matrix-associatedserine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: Heparin accelerates the activity of TFPI-2/MSPI toward plasmin

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    95. Tohgi, H; Utsugisawa, K; Yoshimura, M; Nagane, Y; Ukitsu, M
      Local variation in expression of pro- and antithrombotic factors in vascular endothelium of human autopsy brain

      ACTA NEUROPATHOLOGICA
    96. IINO M; FOSTER DC; KISIEL W
      QUANTIFICATION AND CHARACTERIZATION OF HUMAN ENDOTHELIAL CELL-DERIVEDTISSUE FACTOR PATHWAY INHIBITOR-2

      Arteriosclerosis, thrombosis, and vascular biology
    97. KLAUSER RJ; HOPPENSTEADT D; FAREED J
      TISSUE FACTOR PATHWAY INHIBITOR IS A POTENT INHIBITOR OF PLASMIN

      Clinical and applied thrombosis/hemostasis
    98. BRIDEY F; LACOMBE C; SUSTENDAL L; MOATTI D; COMBE F; MAMMES O; DEPROST D
      DEVELOPMENT OF A METHOD TO SEPARATE LIPOPROTEIN-BOUND AND LIPOPROTEIN-DEPLETED TISSUE FACTOR PATHWAY INHIBITOR - MEASUREMENT OF FREE TISSUEFACTOR PATHWAY INHIBITOR ACTIVITY

      Blood coagulation & fibrinolysis
    99. FALKON L; GARI M; BARBANOJ M; AMIRAL J; FONTCUBERTA J
      TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES

      Blood coagulation & fibrinolysis
    100. RAO LVM; PENDURTHI UR
      TISSUE FACTOR ON CELLS

      Blood coagulation & fibrinolysis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 00:18:56